TANBead (6797) has been benefited from the huge demand for nucleic acid extraction solutions driven by the COVID-19 Virus. The company has key technology of nano magnetic beads, has accumulated many years of research and development experience to launched three major operation modes.
First is the ODM and OEM services. TANBead has cooperated with a total of three biotech companies in Europe and the United States to provide the middle to large throughput models and extraction reagents.
Secondly, the production platform installation solution. We have been introduced into automated filling line systems for many years, and its advantages include improved production efficiency, product quality assurance, and ease of use.
Lastly, the existing nucleic acid purification market. According to BIS Research 2021, the scientific research market is the largest and fastest growing region in the global nucleic acid purification market. The Maelstrom Switch 8 is expected to be launched next year to satisfy users' needs for diversity in testing. The gearbox switching modules can be replaced on the same instrument to perform volume extraction of different samples.
This cost-effective feature is competitive in the market, and was deeply impressed by customers at this year's American Association for Clinical Chemistry (AACC), adding motivation to the company's revenue. It’s expected that this product line can provide a certain degree of revenue growth in the future.
